Ke Wang - Researcher Profile | RDL Research Database

Publications

3 shown

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Bin Cao , Yeming Wang , Danning Wen +62 more

In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir-ritonavir treatment beyond standard care. Future trials in patients with severe illne...

2020 New England Journal of Medicine 5444 citations

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Xiaochen Li , Shuyun Xu , Muqing Yu +15 more

2020 Journal of Allergy and Clinical Immun... 2341 citations

Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions

Zifeng Yang , Zhiqi Zeng , Ke Wang +23 more

Our dynamic SEIR model was effective in predicting the COVID-19 epidemic peaks and sizes. The implementation of control measures on January 23 2020 was indispensable in reducing...

2020 Journal of Thoracic Disease 1473 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 9,258
Institution: Capital Medical University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-2554-9628

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.